BBC By Smitha Mundasad Dec. 22, 2014
The first-ever trial of an Ebola vaccine in Africa shows promising initial results, according to a report in the Lancet medical journal.
Scientists say it is a crucial step as other vaccines have shown lower levels of protection in African populations.
Tests involving Ugandan and American volunteers reveal the vaccine is so far safe and generates an immune response in both populations.
It provides reassurance for other trials currently underway, they say.
No proven vaccine exists to prevent people from getting the disease, though several trials are underway.
Researchers from the National Institutes of Health tested this experimental vaccine on healthy adults in Uganda, having first trialled it in the United States.
Dr Julie Ledgerwood, the lead researcher, said: "This is the first study to show comparable safety and immune response of an experimental Ebola vaccine in an African population.
Read complete story
http://www.bbc.com/news/health-30577776
Recent Comments